Status:
ACTIVE_NOT_RECRUITING
Early Percutaneous Mitral Intervention in Asymptomatic Moderate Mitral Stenosis
Lead Sponsor:
Asan Medical Center
Conditions:
Moderate Mitral Stenosis
Eligibility:
All Genders
20-70 years
Phase:
NA
Brief Summary
Although percutaneous mitral commissurotomy (PMC) has been accepted as an effective treatment for symptomatic patients with moderate or severe mitral stenosis (MS), most asymptomatic patients are not ...
Detailed Description
We enroll consecutive asymptomatic patients with moderate mitral stenosis who are candidates for both early percutaneous mitral commissurotomy (PMC) and conventional treatment at 3 centers in Seoul, K...
Eligibility Criteria
Inclusion
- asymptomatic patients with moderate MS who are potential candidates for early percutaneous mitral commissurotomy
Exclusion
- patients with exertional dyspnea
- total echocardiographic score \> 10
- moderate to severe mitral regurgitation
- left atrial thrombi
- significant aortic valve disease,
- left ventricle (LV) ejection fraction (EF) \<50%
- Doppler-estimated pulmonary artery systolic pressure \>50 mmHg
- those who were not candidates for early intervention based on age \> 70 years or the presence of coexisting malignancies
Key Trial Info
Start Date :
July 29 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2026
Estimated Enrollment :
167 Patients enrolled
Trial Details
Trial ID
NCT01406353
Start Date
July 29 2011
End Date
May 1 2026
Last Update
November 17 2025
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Asan Medical Center
Seoul, South Korea, 138-736
2
Samsung Medical Center
Seoul, South Korea
3
Yonsei University Severance Hospital
Seoul, South Korea